Headaches and Injection Site Reactions Headaches and injection site reactions, including mild redness or irritation at the weekly injection site, were also documented in trial participants, though these were less commonly reported than gastrointestinal symptoms
When to Consider Medical GLP-1 Treatment Options Whilst natural approaches to enhancing GLP-1 can benefit many individuals, certain clinical situations warrant consideration of pharmaceutical GLP-1 receptor agonists
Tirzepatide has been through a comprehensive Phase 3 program (SURMOUNT for obesity, SURPASS for diabetes) with thousands of participants, multiple comparators, and up to 72 weeks of follow-up
Everyone here was very polite and very welcoming
That figure rivals the best results from semaglutide and tirzepatide head-to-head trials , and retatrutide achieved it with a shorter observation period
It also includes GLP-1 companion products used during care